Acadia Healthcare (ACHC) director awarded 6,331 shares vesting over 3 years
Rhea-AI Filing Summary
GRIECO WILLIAM reported acquisition or exercise transactions in this Form 4 filing.
Acadia Healthcare Company, Inc. director William Grieco received an equity grant of 6,331 shares of Common Stock as compensation. The shares were awarded at no cash cost to him and increase his directly held stake to 96,212 shares.
The granted shares will vest over three years in equal yearly installments beginning on May 6, 2027, meaning he earns the shares gradually over time as service continues on the board.
Positive
- None.
Negative
- None.
Insider Trade Summary
Net Buyer: 6,331 shares
Net Buy
1 txn
Insider
GRIECO WILLIAM
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock | 6,331 | $0.00 | $0.00 |
Holdings After Transaction:
Common Stock — 96,212 shares (Direct)
Footnotes (1)
- F1. Shares will vest over a 3-year period in equal yearly installments beginning May 6, 2027.
Key Figures
Shares granted: 6,331 shares
Shares after transaction: 96,212 shares
Grant price per share: $0.0000 per share
+1 more
4 metrics
Shares granted
6,331 shares
Equity grant to director on May 6, 2026
Shares after transaction
96,212 shares
Total Common Stock directly held by William Grieco after grant
Grant price per share
$0.0000 per share
Indicates stock-based compensation, not a cash purchase
Vesting period
3 years
Award vests in equal yearly installments beginning May 6, 2027
Key Terms
Grant, award, or other acquisition, vest, Form 4
3 terms
Grant, award, or other acquisition financial
"transaction_code_description: Grant, award, or other acquisition"
vest financial
"Shares will vest over a 3-year period in equal yearly installments"
A vest is the process by which an employee earns the right to receive certain benefits or ownership interests, such as stock or retirement funds, over time. It’s similar to earning a reward gradually, ensuring that the benefit becomes fully yours only after a set period or meeting specific conditions. This makes it important for investors because it determines when they can actually claim or use those benefits.
Form 4 regulatory
"INSIDER FILING DATA (Form 4)"
Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.
AI-generated analysis. How Rhea-AI works. Not financial advice.